We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The FDA is alerting clinical trial sponsors whose institutional review boards (IRBs) review FDA-regulated research that the boards are not considered registered if they have not filed an initial registration or provided information required by the IRB registration rule.